Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 109.74 -2.27 (-2.03%) Market Cap: 6.92 Bil Enterprise Value: 11.03 Bil PE Ratio: 22.63 PB Ratio: 1.87 GF Score: 78/100

Jazz Pharmaceuticals PLC at Barclays Global Healthcare Conference Transcript

Mar 10, 2020 / 01:30PM GMT
Release Date Price: $112.79 (+2.12%)
Operator

You may begin, sir.

Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good morning, everyone. Thank you for dialing in. My name is Balaji Prasad. I cover specialty pharma for Barclays. Owing to the special circumstances we are in, this is a novel format for us to host a virtual health care conference. So thank you for dialing in.

Continuing with the day's sessions, we have with us today Dan Swisher, President of Jazz Pharmaceuticals; Rob Iannone, EVP, R&D; and Kathee and Diane from the Investor Relations team. Thank you all for dialing in.

Also, owing to the nature of this format, there will be no Q&A session. Rob, Dan, Kathee and Diane, good morning.

Daniel N. Swisher
Jazz Pharmaceuticals plc - President & COO

Good morning.

Katherine A. Littrell
Jazz Pharmaceuticals plc - VP of IR

Good morning.

Robert Iannone
Jazz Pharmaceuticals plc - EVP of Research & Development

Good

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot